Human cancer-associated mutations in the A? subunit of protein phosphatase 2A increase lung cancer incidence in A? knock-in and knockout mice.
Ontology highlight
ABSTRACT: Strong evidence has indicated that protein phosphatase 2A (PP2A) is a tumor suppressor, but a mouse model for testing the tumor suppressor activity was missing. The most abundant forms of trimeric PP2A holoenzyme consist of the scaffolding A? subunit, one of several regulatory B subunits, and the catalytic C? subunit. A? mutations were discovered in a variety of human carcinomas. All carcinoma-associated mutant A? subunits are defective in binding the B or B and C subunits. Here we describe two knock-in mice expressing cancer-associated A? point mutants defective in binding B' subunits, one knockout mouse expressing truncated A? defective in B and C subunit binding, and a floxed mouse for generating conditional A? knockouts. We found that the cancer-associated A? mutations increased the incidence of cancer by 50 to 60% in lungs of FVB mice treated with benzopyrene, demonstrating that PP2A acts as a tumor suppressor. We show that the effect of A? mutation on cancer incidence is dependent on the tumor suppressor p53. The finding that the A? mutation E64D, which was detected in a human lung carcinoma, increases the lung cancer incidence in mice suggests that this mutation also played a role in the development of the carcinoma in which it was discovered.
SUBMITTER: Ruediger R
PROVIDER: S-EPMC3165721 | biostudies-literature | 2011 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA